Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
Condition: PCOS Interventions: Drug: Sitagliptin; Behavioral: Lifestyle intervention Sponsor: University Medical Centre Ljubljana Completed - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Janumet | Januvia | Metformin | Obesity | Ovaries | Polycystic Ovary Syndrome | Research | Women